Stay updated on Nivolumab for IDH Mutant Gliomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.
Latest updates to the Nivolumab for IDH Mutant Gliomas Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.2 was added and v3.3.1 removed; this is a minor site maintenance update and does not alter study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check13 days agoChange DetectedA bibliographic citation in the Publications section was added and an older version of the same citation was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check20 days agoChange DetectedThe government funding/operating status notice is removed from the page; trial details, eligibility, and outcomes remain the same.SummaryDifference0.4%
- Check27 days agoChange DetectedThe page now includes posted results (Results First Posted/Submitted) and a new PDF for the Study Protocol and SAP; enrollment and completion dates are updated and the study status is now Completed.SummaryDifference2%
- Check34 days agoChange DetectedThe page shows only minor textual edits and formatting adjustments in the Study Details section, with core content such as eligibility criteria, outcomes, and intervention unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check56 days agoChange DetectedAdded: Results Submitted. Removed: No Results Posted.SummaryDifference0.1%
Stay in the know with updates to Nivolumab for IDH Mutant Gliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.